United States Livestock Vaccines Market Insights Forecasts to 2033

• The U.S. Livestock Vaccines Market Size was valued at USD 2.47 Billion in 2023.
• The Market is Growing at a CAGR of 6.48% from 2023 to 2033
• The U.S. Livestock Vaccines Market Size is Expected to Reach USD 4.63 Billion by 2033

The U.S. Livestock Vaccines Market Size is Anticipated to Exceed USD 4.63 Billion by 2033, Growing at a CAGR of 6.48% from 2023 to 2033.

Market Overview

Livestock vaccines have been proven to help avert an outbreak while controlling economic loss in relation to farm animals. These vaccinations come in handy in preventing outbreaks by inoculating various diseases such as foot and mouth diseases. The livestock vaccines are administered in various routes, which include intravascular, subcutaneous, spray, oral, and nasal. In addition, the veterinary vaccines for farm animals have been classified under many types such as live attenuated vaccine, inactivated vaccine, toxoid vaccine, and recombinant vaccine. The U.S. have faced a high prevalence of livestock and zoonotic diseases. This has increased the numbers of farm animals getting vaccinated thereby forcing the government to pay greater attention towards disease prevention and control. Moreover, market players' surge in vaccine introduction is also projected to increase demand for vaccines over the next few years. For instance, in March 2023, National Foundation for Infectious Diseases reported that approximately 5,000 cases of animal rabies are reported annually in the U.S. Increasing adoption of vaccination among farmers who own livestock and veterinarians driven by a relentless campaign to understand vaccination programs for the treatment of livestock suffering from diseases is expected to drive this market.

Report Coverage

This research report categorizes the market for the US livestock vaccines market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States livestock vaccines market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the U.S. livestock vaccines market.

Driving Factors

The government, in recent years, has been keen on vaccination programs in the U.S. to protect the livestock population from contagious diseases. The government supports these vaccination programs as a preventive measure that will keep livestock owners and farmers vaccinating their animals. The USDA invested USD 27.1 million in FMD vaccines into the National Animal Vaccine and Veterinary Countermeasures Bank in July 2020. This vaccine purchase offered the government an avenue to respond to animal disease outbreaks.

Restraining Factors

Although the use of vaccines in farm animals has gained high acceptance within the country, the possibility of side effects in such products poses a few concerns. The animal side effects in the form of allergic reactions, injection site reaction, etc, sometimes associated with these livestock vaccines may pose a risk.

Market Segmentation

The US livestock vaccines market share is classified into type and distribution channel.

• The live attenuated segment is expected to hold a significant market share through the forecast period.

The United States livestock vaccines market is segmented, by type into inactivated, live attenuated, recombinant, and others. Among these, the live attenuated segment is expected to hold a significant market share through the forecast period. Because of the increasing number of launches of advanced live attenuated vaccines for farm animals together with the growing outbreaks of diseases in the country. Besides, live attenuated swine vaccines given through intramuscular methods will most certainly accelerate segmental growth.

• The bovine segment is expected to dominate the US livestock vaccines market during the projected period.

Based on the animal type, the United States livestock vaccines market is divided into bovine, swine/ porcine, poultry, and others. Among these, the bovine segment is expected to dominate the US livestock vaccines market during the projected period. This dominance will be driven by the major population of cattle within the U.S. and an overall increasing need for beef and dairy products. Also, a rising awareness in the management and prevention of diseases in cattle along with the regulatory regulation of the use of vaccines contributes to the demand for bovine vaccines.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States livestock vaccines market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim International GmbH
• Virbac
• Merck Animal Health (Merck & Co., Inc.)
• Zoetis Services LLC
• Ceva
• Elanco
• Neogen Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2023, The Kansas State University's College of Veterinary Medicine recently announced the creation of a Center on Vaccine Evaluation and Alternatives for Antimicrobials. This center is expected to facilitate research and development of new and innovative vaccines for livestock and animals.

Market Segment

This study forecasts revenue at U.S., regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States livestock vaccines market based on the below-mentioned segments:

United States Livestock Vaccines Market, By Type

• Inactivated
• Live Attenuated
• Recombinant
• Others

United States Livestock Vaccines Market, By Animal Type

• Bovine
• Swine/ Porcine
• Poultry
• Others